News

Revo Sunglasses Launches Special Promotions for Eye Health

Revo Sunglasses Launches Special Promotions for Eye Health

Revo Sunglasses Launches Special Promotions for Eye Health

"Shop and Give" at Revo's SoHo NYC Store or Take 20% Off Online with Code MRF20

Revo, a leader in high-performance polarized sunglasses, is thrilled to announce an ongoing commitment to support the Melanoma Research Foundation (MRF) during the important #EyeGetDilated Ocular Melanoma Awareness Month this November.

Shop and Give Campaign

This November, Revo's flagship store in SoHo will host a unique "Shop and Give" campaign. Customers visiting the store can contribute to the MRF, as a part of all in-store sales will be donated to aid in research, education, and advocacy endeavors surrounding ocular melanoma (OM), which is known to be the most common primary eye tumor among adults.

Exclusive Online Offer

For those preferring to shop online, Revo is offering a fantastic 20% discount on all sunglasses available at Revo.com, utilizing the promotional code MRF20. This special offer is valid through the end of the month, providing customers with a wonderful opportunity to purchase quality eyewear while aiding important research efforts.

Giving Tuesday Event

As part of this month-long initiative, Revo plans to host a special event on Giving Tuesday. This gathering will connect OM survivors with medical professionals to discuss the significance of protective eyewear and the necessity of annual dilated eye exams, which are critical for early detection of ocular melanoma. This evening promises to not only raise awareness about this serious disease but also celebrate the partnership between Revo and MRF.

Commitment to Eye Health

Cliff Robinson, CEO of Revo, expressed, "Our partnership with the Melanoma Research Foundation reflects Revo's unwavering commitment to protecting eyes from harmful UV rays while supporting life-saving research. By joining forces with MRF, we advocate for sun safety and emphasize the importance of routine eye exams for the early detection of ocular melanoma. We are honored to contribute to this vital cause and invite our customers to join us through these promotional efforts."

The Importance of Early Detection

Each year, ocular melanoma affects around 2,000 individuals within the U.S., often presenting few or no symptoms during its early stages. Hence, regular dilated eye exams are crucial for early detection. The MRF promotes these exams for everyone, regardless of vision issues, as a vital part of annual wellness routines through its engaging #EyeGetDilated initiative. Revo's polarized lenses provide essential UV protection, becoming a valuable asset for eye safety and melanoma prevention.

For further insights on ocular melanoma and details about the MRF's CURE OM initiative, individuals are encouraged to explore relevant resources available online.

About Revo

Founded in 1985, Revo has established itself as a prominent name in the world of performance eyewear, recognized for its pioneering polarized lens technology. Originally developed using NASA technology for satellite protection, Revo sunglasses epitomize quality and innovation. Over 35 years later, the brand continues to excel in providing the clearest and most advanced polarized eyewear on the market.

Frequently Asked Questions

What is the #EyeGetDilated campaign?

The #EyeGetDilated campaign is an initiative by the Melanoma Research Foundation aimed at raising awareness about ocular melanoma and encouraging regular eye exams.

How can I participate in the Revo promotions?

You can participate by shopping at Revo's SoHo store or online using the code MRF20 for a 20% discount on all sunglasses.

When is the Giving Tuesday event?

The Giving Tuesday event will take place on a designated date in December at the Revo SoHo store and will feature discussions led by survivors and medical professionals.

What is ocular melanoma?

Ocular melanoma is the most common primary eye tumor in adults, affecting thousands each year, often with minimal symptoms in its early stages.

Why are dilated eye exams important?

Dilated eye exams are critical for the early detection of ocular melanoma, allowing for timely intervention and treatment.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 584

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

Updated Category News Views 128

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 207

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 114

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 353

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Telespazio & Rivada Forge Secure Satellite Network

Updated Category News Views 61

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 83

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
AI Tool Identifies PTSD in ER: Game-changer?

Updated Category News Views 18

Pushing Boundaries: AI and Emergency Room Narratives When you think about the chaos of an emergency room, PTSD might not be the first thing that comes to mind. But for the folks developing cutting-edge AI at NYU Langone Health, it's a crucial window of opportunity. Enter PREVIA, an AI tool that’s been tapping into patients’ narratives to pinpoint PTSD risks with...

Continue Reading
EICMA 2026: Groundbreaking Moves in Two-Wheel World

Updated Category News Views 9

Revving Up in Milan: A Record-Breaking EICMA If you're into two-wheelers as much as stocks, EICMA 2026 is where all the action is happening. They opened the door with a bang at Fiera Milano Rho, pulling off their biggest showcase yet. Ten halls packed to the brim, up from nine the previous year, creating buzz across the globe. Showcasing 765 exhibitors and 2,142 brands...

Continue Reading
Nutex Health Scores Top Workplace Honor in 2026

Updated Category News Views 43

Nutex Health: Accolades and Aspirations Nutex Health just snagged something pretty noteworthy: They've been crowned a 2026 Houston Top Workplace by the Houston Chronicle. Now, before you start throwing confetti, let's chew on what this really means. It's no small potatoes, folks. We're talking employee respect and satisfaction measured by Energage’s surveys. It's proof...

Continue Reading

Top 5 Most Recently Viewed Articles

Orla Mining's Earnings Predictions and Market Insights

Updated Category News Views 537

Anticipated Earnings Release for Orla Mining Orla Mining (AMEX: ORLA) is set to unveil its quarterly earnings, and investors are keenly observing the upcoming report. Analysts are projecting the company will announce an earnings per share (EPS) of $0.20, which generates a mix of anticipation and excitement in the market. Insights Into Previous Earnings Performance In the...

Continue Reading
Bar Leone Reigns Supreme as Asia's Best Bar Again

Updated Category News Views 209

Bar Leone Recognized as Asia's Leading Bar for Two Years Bar Leone has once again captured the prestigious title of The Best Bar in Asia, an accolade it earned for the second consecutive year at the Asia's 50 Best Bars ceremony. This recognition, sponsored by Perrier, marks a significant milestone in the vibrant cocktail culture across the continent. Outstanding...

Continue Reading
Commvault Faces Securities Fraud Lawsuit: What's Next?

Updated Category News Views 36

Unpacking Commvault's Legal Headaches There's fresh trouble brewing in the world of Commvault Systems Inc. (NASDAQ: CVLT). Investors licking their wounds have a chance to rally in a securities fraud class action lawsuit. It all circles back to some allegedly shady moves—or, more precisely, what the company didn't spill between April 2025 and January 2026. The Crux of...

Continue Reading
Investigating Lumos Pharma's Acquisition: Implications for Shareholders

Updated Category News Views 76

Investigation into Lumos Pharma's Proposed Acquisition Rowley Law PLLC is currently looking into potential securities law violations related to Lumos Pharma, Inc. (NASDAQ: LUMO). This investigation centers around the proposed acquisition of Lumos Pharma by Double Point Ventures LLC. Under the terms of this acquisition, shareholders are set to receive $4.25 along with one...

Continue Reading
LKQ Faces Investor Suit: Key Impacts & Deadlines

Updated Category News Views 17

LKQ's Acquisition Missteps Ignite Investor Action Just when you think you've seen it all in the stock market, something like this drops—another punch in the gut reminding us that no company is impervious to stumbling. LKQ Corporation (NASDAQ: LKQ) has got itself tangled in some messy legal affairs, thanks to a string of ugly truths coming to light from its pricey $2.1...

Continue Reading